John Frederick Ek - 01 Apr 2025 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
CFO
Signature
/s/ John Frederick Ek, by Brian McKelligon, as Attorney-in-Fact
Issuer symbol
AKYA
Transactions as of
01 Apr 2025
Net transactions value
-$22,183
Form type
4
Filing time
03 Apr 2025, 17:14:37 UTC
Previous filing
04 Mar 2025
Next filing
10 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Tax liability $22,183 -16,432 -6.2% $1.35 248,202 01 Apr 2025 Direct F1
holding AKYA Common Stock 20,000 01 Apr 2025 Ek Trust Dated November 20, 2020
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to cover taxes on a restricted stock unit award previously granted on March 20, 2023, which vests in four (4) annual equal installments beginning on April 1, 2024 and annually thereafter until fully vested.